Home Clinical Topics FDA permits marketing of new device for treating diabetic foot ulcers

FDA permits marketing of new device for treating diabetic foot ulcers

Author(s):

On December 28, 2017, the U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.

Read more via Fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here